{"id":"https://openalex.org/W4322772298","doi":"https://doi.org/10.1158/1538-7445.sabcs22-her2-10","title":"Abstract HER2-10: HER2-10 Dynamics of HER2-low expression in triple-negative breast cancer","display_name":"Abstract HER2-10: HER2-10 Dynamics of HER2-low expression in triple-negative breast cancer","publication_year":2023,"publication_date":"2023-03-01","ids":{"openalex":"https://openalex.org/W4322772298","doi":"https://doi.org/10.1158/1538-7445.sabcs22-her2-10"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs22-her2-10","doi":"https://doi.org/10.1158/1538-7445.sabcs22-her2-10","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs22-her2-10","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024995771","display_name":"Ana Christina Garrido-Castro","orcid":"https://orcid.org/0000-0002-5989-6636","observed_orcids":["https://orcid.org/0000-0002-5989-6636"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ana C. Garrido-Castro","raw_affiliation_strings":["1Dana-Farber/Brigham and Women\u2019s Cancer Center; Harvard Medical School","Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber/Brigham and Women\u2019s Cancer Center; Harvard Medical School","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210161994"]},{"raw_affiliation_string":"Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020627225","display_name":"Lan D. Ngo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lan D. Ngo","raw_affiliation_strings":["2Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037645425","display_name":"Edward T. Richardson","orcid":"https://orcid.org/0000-0002-7576-2603","observed_orcids":["https://orcid.org/0000-0002-7576-2603"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward T. Richardson","raw_affiliation_strings":["3Brigham and Women\u2019s Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021078579","display_name":"Allison Frangieh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison Frangieh","raw_affiliation_strings":["4Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031854515","display_name":"Ayesha Mohammed-Abreu","orcid":"https://orcid.org/0009-0000-2711-9624","observed_orcids":["https://orcid.org/0009-0000-2711-9624"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ayesha Mohammed-Abreu","raw_affiliation_strings":["5Dana Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Dana Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015055171","display_name":"Melissa E. Hughes","orcid":"https://orcid.org/0000-0001-6190-9101","observed_orcids":["https://orcid.org/0000-0001-6190-9101"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa E. Hughes","raw_affiliation_strings":["6Dana Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Dana Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042886213","display_name":"Jorge G\u00f3mez Tejeda Za\u00f1udo","orcid":"https://orcid.org/0000-0002-1092-0068","observed_orcids":["https://orcid.org/0000-0002-1092-0068"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jorge Gomez Tejada Zanudo","raw_affiliation_strings":["7Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Dana-Farber Cancer Institute, Broad Institute of MIT and Harvard","institution_ids":["https://openalex.org/I107606265","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078538229","display_name":"John Navarro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Navarro","raw_affiliation_strings":["8Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081854007","display_name":"Paolo Tarantino","orcid":"https://orcid.org/0000-0001-8686-0228","observed_orcids":["https://orcid.org/0000-0001-8686-0228"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paolo Tarantino","raw_affiliation_strings":["9Breast Oncology Program, Dana-Farber Cancer Institute; Harvard Medical School, Boston, Massachusetts","Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Breast Oncology Program, Dana-Farber Cancer Institute; Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029062544","display_name":"Elizabeth Ann Mittendorf","orcid":"https://orcid.org/0000-0002-9762-8536","observed_orcids":["https://orcid.org/0000-0002-9762-8536"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Mittendorf","raw_affiliation_strings":["10DANA-FARBER CANCER INSTITUTE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10DANA-FARBER CANCER INSTITUTE","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069056507","display_name":"Sara M. Tolaney","orcid":"https://orcid.org/0000-0002-5940-8671","observed_orcids":["https://orcid.org/0000-0002-5940-8671"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara Tolaney","raw_affiliation_strings":["11Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076310424","display_name":"Tari A. King","orcid":"https://orcid.org/0000-0003-3602-2351","observed_orcids":["https://orcid.org/0000-0003-3602-2351"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tari King","raw_affiliation_strings":["12Division of Breast Surgery, Department of Surgery, Brigham and Women\u2019s Hospital, Breast Oncology Program, Dana-Farber/Brigham and Women\u2019s Cancer Center, Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Division of Breast Surgery, Department of Surgery, Brigham and Women\u2019s Hospital, Breast Oncology Program, Dana-Farber/Brigham and Women\u2019s Cancer Center, Harvard Medical School","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070245248","display_name":"Eric P. Winer","orcid":"https://orcid.org/0000-0002-8819-1723","observed_orcids":["https://orcid.org/0000-0002-8819-1723"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Winer","raw_affiliation_strings":["13Yale Cancer Center, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Yale Cancer Center, New Haven, CT","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022319770","display_name":"NU Lin","orcid":"https://orcid.org/0000-0003-2263-5413","observed_orcids":["https://orcid.org/0000-0003-2263-5413"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy U. Lin","raw_affiliation_strings":["14Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068721624","display_name":"Nikhil Wagle","orcid":"https://orcid.org/0000-0003-3332-9438","observed_orcids":["https://orcid.org/0000-0003-3332-9438"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil Wagle","raw_affiliation_strings":["15Dana-Farber Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"5_Supplement","first_page":"HER2","last_page":"10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-low","display_name":"HER2-low","score":0.8730000257492065},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.968999981880188},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8019999861717224},{"id":"https://openalex.org/keywords/residual-disease","display_name":"residual disease","score":0.5899999737739563},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8690000176429749},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.47200000286102295},{"id":"https://openalex.org/keywords/her2-antibody-drug-conjugate","display_name":"HER2 antibody-drug conjugate","score":0.5730000138282776},{"id":"https://openalex.org/keywords/her2-amplification","display_name":"HER2 amplification","score":0.31299999356269836},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.33899998664855957}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8098088502883911},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7628315091133118},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.7104990482330322},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.6245943307876587},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.592562735080719},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5880759358406067},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.5724039673805237},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5438230633735657},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.520514190196991},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.4937656819820404},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4253527522087097},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.34908705949783325},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs22-her2-10","doi":"https://doi.org/10.1158/1538-7445.sabcs22-her2-10","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs22-her2-10","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3173135777","https://openalex.org/W4281608872","https://openalex.org/W4384200286","https://openalex.org/W4387808261","https://openalex.org/W4321497618","https://openalex.org/W4379282808","https://openalex.org/W4322772318","https://openalex.org/W4220989722","https://openalex.org/W3205002341","https://openalex.org/W3027874779"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"With":[2],"the":[3,17,160,251,262,402,414,529,644],"development":[4],"of":[5,63,67,105,198,311,528,538,633,643],"novel":[6],"antibody":[7],"drug":[8],"conjugates":[9],"(ADC),":[10],"it":[11],"is":[12],"increasingly":[13],"important":[14],"to":[15,28,327,450,458,481,542,585],"understand":[16],"changes":[18,93,561],"that":[19],"occur":[20],"in":[21,33,47,74,84,94,97,159,241,275,338,344,349,396,442,474,497,503,510,516,525,544,582,636],"cell-surface":[22],"targets":[23],"over":[24,109],"time":[25,82,331],"from":[26,115,448,456,540],"early-stage":[27],"metastatic":[29,45,153,186],"breast":[30,52,132,154,252,340,477,499,512,638],"cancer.":[31,155],"Discordance":[32],"HER2":[34,78,95,195,215,222,322,360,366,392,438,471,520,559,588],"expression":[35,64,635],"per":[36,55,330,565],"immunohistochemistry":[37],"(IHC)":[38],"has":[39,71,86],"been":[40,72,88],"reported":[41],"between":[42,138],"primary":[43],"and":[44,61,77,140,183,211,225,293,346,375,377,381,390,431,435,455,478,500,513,549,568,577],"tumors":[46,70],"patients":[48,98],"(pts)":[49],"with":[50,58,100,149,179,266,282,295,387,534],"HER2-negative":[51],"cancer":[53,133,639],"defined":[54],"ASCO/CAP":[56],"guidelines,":[57],"both":[59,545],"gain":[60],"loss":[62],"described.":[65,89],"Representation":[66],"HR-negative":[68],"(TNBC)":[69],"limited":[73],"these":[75,583],"studies,":[76],"status":[79],"at":[80,134,212,411,423],"multiple":[81,563],"points":[83],"TNBC":[85,172,182,187,530],"not":[87],"Here":[90],"we":[91,532],"report":[92],"IHC":[96,196,216,223,238,268,323,367,393,439,472,490,495,501,508,514,521,560],"diagnosed":[99,178,281],"TNBC,":[101],"using":[102],"a":[103,142,309],"collection":[104],"matched":[106,235],"tumor":[107],"samples":[108,199,313,352,356,584],"time.":[110],"Methods:":[111],"Pts":[112,156],"were":[113,157,177,192,279,369,485],"identified":[114],"two":[116],"sources:":[117],"1)":[118],"an":[119],"institutional":[120],"database":[121],"including":[122,571],"all":[123,307,354],"consecutive":[124],"pts":[125,148,274,386,428],"who":[126,429],"underwent":[127,288],"surgery":[128,289],"for":[129,147,169,194,371],"stage":[130,170,181],"I-III":[131,171],"Dana-Farber/Brigham":[135],"Cancer":[136,649,660],"Center":[137],"2015-2018,":[139],"2)":[141],"prospective":[143],"research":[144],"biopsy":[145,265],"protocol":[146],"known":[150],"or":[151,174,229],"suspected":[152],"included":[158],"present":[161],"analysis":[162],"if":[163,175,209,221,227,237,255],"they":[164,176],"received":[165,285],"neoadjuvant":[166],"chemotherapy":[167],"(NAC)":[168],"(eTNBC),":[173],"any":[180],"ultimately":[184],"developed":[185],"(mTNBC).":[188],"Clinical":[189],"pathology":[190],"records":[191],"reviewed":[193],"results":[197],"collected":[200],"at:":[201],"initial":[202],"diagnosis":[203],"(DX);":[204],"residual":[205],"disease":[206],"(RD)":[207],"post-NAC,":[208,548],"applicable;":[210],"recurrence":[213],"(M).":[214],"was":[217,239,253,269,301,335,394,440,452,460,523],"classified":[218],"as":[219,290],"HER2-0":[220,404,422,449,459,543],"0,":[224,488],"HER2-low":[226,333,410,416,457,541,634],"1+":[228,509],"2+":[230,502],"(and":[231],"ISH":[232],"non-amplified).":[233],"For":[234],"comparisons,":[236],"performed":[240],"more":[242,256,535],"than":[243,257],"one":[244,258,328,359,493,506],"DX":[245,339,374,380,389,405,417,434,476,498,511],"sample":[246,329],"(e.g.,":[247],"breast,":[248],"node),":[249],"only":[250,261],"considered;":[254],"M":[259,264,351,382,436,479,504,517],"sample,":[260],"first":[263,291,350],"available":[267,321,370,473],"considered.":[270],"Results:":[271],"Among":[272,306,384,425,463],"110":[273],"this":[276],"cohort,":[277],"101":[278],"initially":[280],"eTNBC":[283,364,427],"(79":[284],"NAC;":[286],"22":[287],"intervention)":[292],"9":[294,464],"de":[296,465],"novo":[297,466],"mTNBC.":[298],"Median":[299],"age":[300],"48.7":[302],"years":[303],"(range":[304],"19.8-71.6).":[305],"pts,":[308,365,468],"total":[310],"292":[312],"(136":[314],"DX,":[315],"53":[316],"RD,":[317,345,376,391],"103":[318],"M)":[319],"had":[320,432,470,494,507],"scores.":[324],"When":[325],"restricting":[326],"point,":[332],"prevalence":[334],"49/102":[336],"(48.0%)":[337],"tumors,":[341,406,418],"21/53":[342],"(39.6%)":[343],"13/58":[347],"(22.4%)":[348],"(with":[353],"remaining":[355],"HER2-0,":[357],"except":[358],"3+":[361],"sample).":[362],"In":[363],"scores":[368],"50":[372,385],"paired":[373,379,388,433,475,546,550],"48":[378,426],"samples.":[383,552],"discordant":[395,441,524],"56%":[397],"(28/50)":[398],"(Table":[399,445],"1).":[400,446],"Of":[401,413],"21":[403],"23.8%":[407],"(5/21)":[408],"became":[409,421],"RD.":[412,424],"29":[415],"51.7%":[419],"(15/29)":[420],"recurred":[430],"samples,":[437],"50%":[443],"(24/48)":[444],"Change":[447],"low":[451],"12.5%":[453],"(3/24),":[454],"66.7%":[461],"(16/24).":[462],"mTNBC":[467],"5":[469],"prior":[480],"starting":[482],"therapy;":[483],"3":[484],"concordant":[486],"(IHC":[487],"n=2;":[489],"1+,":[491],"n=1),":[492],"0":[496,515],"(liver),":[505],"(node).":[518],"Conclusions:":[519],"classification":[522],"about":[526],"half":[527],"cases":[531],"examined,":[533],"frequent":[536],"rates":[537],"conversion":[539],"DX/RD":[547],"DX/M":[551],"Additional":[553],"analyses":[554],"will":[555],"be":[556],"presented":[557],"exploring":[558],"among":[562],"metastases":[564],"patient.":[566],"Genomic":[567],"molecular":[569],"analysis,":[570],"whole":[572],"exome":[573],"sequencing,":[574,576],"RNA":[575],"methylation":[578],"profiling,":[579],"are":[580],"underway":[581],"further":[586],"elucidate":[587],"evolutionary":[589],"dynamics.":[590],"Citation":[591],"Format:":[592],"Ana":[593],"C.":[594],"Garrido-Castro,":[595],"Lan":[596],"D.":[597],"Ngo,":[598],"Edward":[599],"T.":[600],"Richardson,":[601],"Allison":[602],"Frangieh,":[603],"Ayesha":[604],"Mohammed-Abreu,":[605],"Melissa":[606],"E.":[607],"Hughes,":[608],"Jorge":[609],"Gomez":[610],"Tejada":[611],"Zanudo,":[612],"John":[613],"Navarro,":[614],"Paolo":[615],"Tarantino,":[616],"Elizabeth":[617],"A.":[618],"Mittendorf,":[619],"Sara":[620],"Tolaney,":[621],"Tari":[622],"King,":[623],"Eric":[624],"Winer,":[625],"Nancy":[626],"U.":[627],"Lin,":[628],"Nikhil":[629],"Wagle.":[630],"HER2-10":[631],"Dynamics":[632],"triple-negative":[637],"[abstract].":[640],"In:":[641],"Proceedings":[642],"2022":[645,651],"San":[646,654],"Antonio":[647],"Breast":[648],"Symposium;":[650],"Dec":[652],"6-10;":[653],"Antonio,":[655],"TX.":[656],"Philadelphia":[657],"(PA):":[658],"AACR;":[659],"Res":[661],"2023;83(5":[662],"Suppl):Abstract":[663],"nr":[664],"HER2-10.":[665]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-03-03T00:00:00"}